What is the USPSTF stance on prophylaxis for gonococcal ophthalmia neonatorum in newborns?

What is the USPSTF stance on prophylaxis for gonococcal ophthalmia neonatorum in newborns?

• A. Prophylactic ocular topical medication for all newborns to prevent gonococcal ophthalmia neonatorum.
• B. Prophaxis only if maternal gonorrhea or chlamydia is known.
• C. No prophylaxis recommended.
• D. Prophylaxis for all infants but only for the first week.

Answer: (A)

Universal prophylaxis of newborn eyes with topical antibiotics at birth is the approach supported to prevent gonococcal ophthalmia neonatorum. Gonorrheal conjunctivitis can develop rapidly after birth if the infant is exposed in the birth canal, and giving prophylactic eye drops or ointment to all newborns ensures immediate protection, including babies whose mothers’ infection status is unknown. This simple, low-cost measure has a strong safety profile and has dramatically reduced the incidence of gonococcal eye infections and the risk of resulting vision loss. It is applied universally rather than reserved only for infants of mothers with known infection, and it is given soon after birth rather than limited to the first week. Note that while prophylaxis protects against gonorrhea in the eye, it does not replace treating the mother for gonorrhea or chlamydia, which remains important for overall maternal and infant health.

Universal prophylaxis of newborn eyes with topical antibiotics at birth is the approach supported to prevent gonococcal ophthalmia neonatorum. Gonorrheal conjunctivitis can develop rapidly after birth if the infant is exposed in the birth canal, and giving prophylactic eye drops or ointment to all newborns ensures immediate protection, including babies whose mothers’ infection status is unknown. This simple, low-cost measure has a strong safety profile and has dramatically reduced the incidence of gonococcal eye infections and the risk of resulting vision loss. It is applied universally rather than reserved only for infants of mothers with known infection, and it is given soon after birth rather than limited to the first week. Note that while prophylaxis protects against gonorrhea in the eye, it does not replace treating the mother for gonorrhea or chlamydia, which remains important for overall maternal and infant health.